Summary
GlobalData’s new report, "United States Nuclear Imaging Equipment Market Outlook to 2022", provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems.
The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Nuclear Imaging Equipment market segments - Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the United States Nuclear Imaging Equipment market.
- Key players covered include Siemens Limited, GE Healthcare Limited, Philips Healthcare and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.
Companies Mentioned
GE Healthcare Ltd
Siemens Limited
Toshiba Medical Systems Corporation
Philips Healthcare
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Nuclear Imaging Equipment Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Nuclear Imaging Equipment Market, United States 8
3.1 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2008-2015 8
3.2 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2015-2022 10
3.3 Nuclear Imaging Equipment Market, United States, Volume (Units), 2008-2015 12
3.4 Nuclear Imaging Equipment Market, United States, Volume (Units), 2015-2022 14
3.5 Nuclear Imaging Equipment Market, United States, Average Price ($), 2008-2022 16
3.6 Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), 2014-2015 18
3.7 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2015 19
4 Overview of Key Companies in United States, Nuclear Imaging Equipment Market 20
4.1 GE Healthcare Ltd 20
4.1.1 Company Overview 20
4.2 Siemens Limited 20
4.2.1 Company Overview 20
4.3 Toshiba Medical Systems Corporation 20
4.3.1 Company Overview 20
4.4 Philips Healthcare 21
4.4.1 Company Overview 21
5 Nuclear Imaging Equipment Market Pipeline Products 22
6 Recent Developments 23
6.1 Corporate Communications 23
6.1.1 Nov 22, 2016: USC Roski Eye Institute conducted patient trials for breakthrough refractory glaucoma treatment 23
6.1.2 Nov 22, 2016: Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma Gene Expression Classifier in 2017 24
6.1.3 Aug 31, 2016: Bruce Elder Named CEO of MedQuest 25
6.2 Financial Announcements 25
6.2.1 Oct 28, 2016: Digirad Reports Financial Results for the Third Quarter and Nine Months ended September 30, 2016 25
6.2.2 Jul 28, 2016: Digirad Reports Financial Results for the Second Quarter and Six Months ended June 30, 2016 26
6.2.3 Apr 29, 2016: Digirad Reports Financial Results for the First Quarter Ended March 31, 2016 27
6.2.4 Feb 26, 2016: Digirad Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2015 28
6.3 Government and Public Interest 29
6.3.1 Jun 14, 2016: Proton Therapy Arrives at Miami Cancer Institute 29
6.4 Legal And Regulatory 30
6.4.1 Feb 25, 2016: SHINE Medical Receives Regulatory Approval: Nuclear Regulatory Commission to Issue Construction Permit 30
6.5 Other Significant Developments 31
6.5.1 Nov 23, 2016: Takeda IBD Treatment ENTYVIO (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award 31
6.5.2 May 11, 2016: NorthStar Medical Radioisotopes Expanding MURR Operations, Quadrupling Molybdenum-99 Dispensing Capacity 32
6.6 Product News 33
6.6.1 Dec 08, 2016: Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT 33
6.6.2 Jul 29, 2016: Hamamatsu Photonics granted patents for Lightsheet Readout Mode in CMOS cameras 33
6.6.3 Jun 10, 2016: NorthStar Medical Radioisotopes Receives Three Patents and Trademark Approval 34
6.6.4 Feb 22, 2016: Bracco Diagnostics Receives Second U.S. FDA Approval for Barium-Based Products, The First in Computed Tomography 34
6.7 Strategy And Business Planning 35
6.7.1 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 35
6.7.2 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 36
7 Appendix 38
7.1 Research Methodology 39
7.1.1 Coverage 39
7.1.2 Secondary Research 39
7.1.3 Primary Research 40
7.1.4 Market Modeling and Forecasting 41
7.1.5 Company Share Analysis 42
7.1.6 Distribution Share Analysis 43
7.1.7 Benchmarking 43
7.2 GlobalData Consulting 43
7.3 Contact Us 44
7.4 Disclaimer 44
1.1 List of Tables
Table 1: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 9
Table 2: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 11
Table 3: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2008-2015 13
Table 4: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2015-2022 15
Table 5: Nuclear Imaging Equipment Market, United States, Average Price ($), Historic, 2008-2015 16
Table 6: Nuclear Imaging Equipment Market, United States, Average Price ($), Forecast, 2015-2022 17
Table 7: Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 18
Table 8: Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2015 19
Table 9: Nuclear Imaging Equipment Market Pipeline Products 22
Table 10: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country 41
1.2 List of Figures
Figure 1: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 8
Figure 2: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Figure 3: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2008-2015 12
Figure 4: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2015-2022 14
Figure 5: Nuclear Imaging Equipment Market, United States, Company Share (%) 2015 19
